Letter

Preventing coronary heart disease: High baseline risk strategy and cost effectiveness of guidelines

BMJ 2006; 332 doi: 10.1136/bmj.332.7544.793 (Published 30 March 2006)
Cite this as: BMJ 2006;332:793.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. D Graham Mackenzie, specialist registrar (gm@nhs.net),
  2. John Forbes, reader in health economics,
  3. Sarah Wild, senior lecturer in public health,
  4. Philip Rutledge, consultant in medicines management
  1. Public Health Department, NHS Fife, Leven, Fife KY8 5RR
  2. School of Clinical Sciences and Community Health, University of Edinburgh, Edinburgh EH8 9AG
  3. Public Health and Health Policy, Lothian NHS Board, Edinburgh EH8 9RS

    EDITOR—Manuel et al found, contrary to Rose's population health strategy, that a high baseline risk strategy was the most effective approach to coronary heart disease prevention with a statin in Canada.1 This approach is consistent with new UK guidelines.2 Using data from the nationally representative Scottish health survey 1998 we estimate that 25% of 40-74 year olds …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular